Mullerian Inhibiting Substance inhibits invasion and migration of epithelial cancer cell lines
- 1 January 2011
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 120 (1), 128-134
- https://doi.org/10.1016/j.ygyno.2010.09.017
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Müllerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeuticsProceedings of the National Academy of Sciences, 2010
- The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor protein and mRNA in benign, borderline and malignant ovarian neoplasiaInternational Journal of Oncology, 2009
- Cell migration and activated PI3K/AKT-directed elongation in the developing rat Müllerian ductDevelopmental Biology, 2008
- Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancerProceedings of the National Academy of Sciences of the United States of America, 2006
- Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsivenessProceedings of the National Academy of Sciences, 2006
- Mullerian Inhibiting Substance Signaling Uses a Bone Morphogenetic Protein (BMP)-Like Pathway Mediated by ALK2 and Induces Smad6 ExpressionMolecular Endocrinology, 2001
- Mullerian-Inhibiting Substance Type II Receptor Expression and Function in Purified Rat Leydig CellsEndocrinology, 1999
- Sequence, Genomic Organization, and Chromosomal Location of the Mouse Müllerian-Inhibiting Substance Type II Receptor GeneBiochemical and Biophysical Research Communications, 1997
- Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the ratEndocrinology, 1992
- Periductal and matrix glycosaminoglycans in rat Mullerian duct development and regressionDevelopmental Biology, 1982